Chembio Diagnostics - Stock Price History | CEMI

Historical daily share price chart and data for Chembio Diagnostics since 2020 adjusted for splits. The latest closing stock price for Chembio Diagnostics as of February 19, 2020 is 3.90.
  • The all-time high Chembio Diagnostics stock closing price was 16.00 on June 08, 2004.
  • The Chembio Diagnostics 52-week high stock price is 7.90, which is 102.6% above the current share price.
  • The Chembio Diagnostics 52-week low stock price is 3.68, which is 5.6% below the current share price.
  • The average Chembio Diagnostics stock price for the last 52 weeks is 5.67.
Chembio Diagnostics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 6.0100 5.6600 7.8500 3.9400 4.5600 -19.43%
2018 8.7806 8.1000 11.5000 4.9500 5.6600 -30.98%
2017 6.2502 6.6500 8.3500 5.2500 8.2000 20.59%
2016 6.7890 5.2100 9.1200 4.2800 6.8000 27.58%
2015 4.5294 3.8700 5.3400 3.5600 5.3300 36.32%
2014 3.5915 3.4000 4.7300 2.8700 3.9100 16.02%
2013 4.4190 4.7501 5.7100 3.2900 3.3700 -28.75%
2012 4.3034 3.4400 5.2599 3.2800 4.7300 40.77%
2011 3.4753 3.2800 4.5600 2.4800 3.3600 -1.18%
2010 2.1713 2.1600 3.6400 1.5200 3.4000 51.79%
2009 1.3250 0.8800 2.9600 0.6400 2.2400 154.55%
2008 1.3837 1.9200 2.4000 0.6000 0.8800 -59.26%
2007 4.6029 6.1600 7.2000 2.1600 2.1600 -67.47%
2006 5.8140 3.0400 8.2400 2.6400 6.6400 137.14%
2005 4.8378 5.7600 6.5600 2.4400 2.8000 -51.39%
2004 10.2441 9.2000 16.0000 4.8000 5.7600 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.071B $0.033B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $157.180B 27.43
Medtronic (MDT) Ireland $151.007B 20.30
Stryker (SYK) United States $83.129B 26.87
Boston Scientific (BSX) United States $58.764B 26.52
Baxter (BAX) United States $47.083B 28.55
EssilorLuxottica Societe Anonyme (ESLOY) France $33.039B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.755B 20.24
Lonza Group Ag (LZAGY) Switzerland $31.832B 0.00
Coloplast (CLPBY) Denmark $30.521B 47.10
Terumo (TRUMY) Japan $26.424B 32.98
ResMed (RMD) United States $25.279B 43.92
Smith & Nephew SNATS (SNN) United Kingdom $20.980B 0.00
Sunny Optical Technology (SNPTF) China $18.537B 0.00
Insulet (PODD) United States $13.123B 624.32
Bio-Rad Laboratories (BIO) United States $12.197B 56.99
Perrigo (PRGO) Ireland $8.024B 14.96
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Canopy Growth (CGC) Canada $7.665B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Hill-Rom Holdings (HRC) United States $7.297B 20.99
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.055B 37.27
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.515B 0.00
ICU Medical (ICUI) United States $4.409B 28.74
NuVasive (NUVA) United States $4.093B 32.23
GW Pharmaceuticals (GWPH) United Kingdom $3.835B 0.00
Neogen (NEOG) United States $3.815B 63.48
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.657B 0.00
Quidel (QDEL) United States $3.345B 29.36
Agios Pharmaceuticals (AGIO) United States $3.137B 0.00
National Vision Holdings (EYE) United States $2.802B 63.25
Aurora Cannabis (ACB) Canada $1.917B 0.00
AtriCure (ATRC) United States $1.707B 0.00
TG Therapeutics (TGTX) United States $1.579B 0.00
Cardiovascular Systems (CSII) United States $1.536B 0.00
InMode (INMD) Israel $1.301B 0.00
NanoString Technologies (NSTG) United States $1.180B 0.00
Aphria (APHA) $1.127B 0.00
Phibro Animal Health (PAHC) United States $1.093B 21.62
VAREX IMAGING (VREX) United States $0.984B 20.45
PetIQ (PETQ) United States $0.960B 23.43
Quanterix (QTRX) United States $0.778B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.727B 27.86
Omeros (OMER) United States $0.674B 0.00
Lantheus Holdings (LNTH) United States $0.650B 16.23
LeMaitre Vascular (LMAT) United States $0.605B 34.41
Surmodics (SRDX) United States $0.523B 60.17
MacroGenics (MGNX) United States $0.514B 0.00
Organigram Holdings (OGI) Canada $0.438B 0.00
HEXO (HEXO) $0.418B 0.00
OraSure Technologies (OSUR) United States $0.406B 24.33
Owens & Minor (OMI) United States $0.404B 14.93
Utah Medical Products (UTMD) United States $0.351B 24.93
Meridian Bioscience (VIVO) United States $0.334B 13.43
Zynex (ZYXI) United States $0.333B 37.70
BioLife Solutions (BLFS) United States $0.318B 129.50
Female Health (VERU) United States $0.286B 0.00
Bovie Medical (APYX) United States $0.259B 0.00
Repro-Med Systems (KRMD) United States $0.237B 0.00
InfuSystems Holdings (INFU) United States $0.220B 1110.00
Vapotherm (VAPO) United States $0.219B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
United Health Products (UEEC) United States $0.192B 0.00
Rockwell Medical (RMTI) United States $0.185B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Cytosorbents (CTSO) United States $0.175B 0.00
Fonar (FONR) United States $0.131B 9.57
Green Organic Dutchman Holdings (TGODF) Canada $0.128B 0.00
Chimerix (CMRX) United States $0.108B 0.00
MRI Interventions (CLPT) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.086B 0.00
United-Guardian (UG) United States $0.081B 20.62
MTech Acquisition (KERN) United States $0.075B 0.00
Nephros (NEPH) United States $0.072B 0.00
FSD PHARMA INC (HUGE) Canada $0.045B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
NF Energy Saving (BIMI) China $0.031B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.007B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Myomo (MYO) United States $0.003B 0.00
Valeritas Holdings (VLRX) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00